VivoSim (NASDAQ: VIVS) is developing human-relevant 3D tissue models designed to improve pharmaceutical decision-making by helping researchers evaluate drug toxicity, efficacy, and safety earlier in the development process.
Stay Ahead Of The Drug Development Shift
VivoSim Inc. (NASDAQ: VIVS) helps pharma identify drug toxicity earlier with human-relevant 3D tissue models.